Paula Deen teams with NJ-based Novo Nordisk on diabetes

Celebrity chef and Food Network star Paula Deen is teaming with New Jersey-based drugmaker Novo Nordisk to launch a program that aims to help people

LITTLE FALLS - Celebrity chef and Food Network star Paula Deen is teaming with New Jersey-based drugmaker Novo Nordisk to launch a program that aims to help people live with Type 2 diabetes and promote a Novo diabetes drug.

The program is called Diabetes in a New Light and offers tips on food preparation, stress management and working with doctors on a treatment plan.

Deen has Type 2 diabetes and takes Victoza, a once-daily noninsulin injection.

Type 2 is the most common form of diabetes. In Type 2 diabetes, the body either does not produce enough insulin or does not use it efficiently, allowing excess sugar, or glucose, to accumulate in the blood.

AP wire services contributed to this report.

Diabetes in a New Light

advertisement | advertise on News 12

Trending Video

On The Road: Point Pleasant Beach preview 1 On The Road: Point Pleasant Beach preview
News 12 New Jersey was on Lloyd Road 2 Powerful storm leaves behind damage across NJ
New Jersey lawmakers held a hearing on immigration. 3 Anxieties ratchet up after Trump immigration crackdown
Fire crews battled a large brush fire in 4 Crews battle brush fire in Keyport
Collection agencies working for the IRS may call 5 Consumer Alert: IRS collections

advertisement | advertise on News 12

Features

It's good to know you have Walt Kane Kane in Your Corner

It's good to know you have Walt Kane in your corner.

News 12 takes a look at the hottest Tech Check

Eric Landskroner has a look at the latest gadgets and biggest stories in tech.

News 12 On the Scene

Check out these exclusive videos from New Jersey celebs!

Sorry to interrupt...

Your first 5 are free

Access to News12 is free for Optimum, Comcast®, Time Warner® and Service Electric℠ video customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE